EP3456744
EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.1.2014EP published:
29.3.2023EP application number:
18186356.4
EPO information:
European Patent Register
Max expiry date:
16.1.2034
Title in English:
EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERSLanguage of the patent:
English
Timeline
Today
17.1.2014EP application
29.3.2023EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
SEXTON, Daniel, J.Address:
Melrose, MA 02176, US
Name:
FAUCETTE, RyanAddress:
Melrose, MA 02176, US
Name:
KENNISTON, Jon, A.Address:
Hingham, MA 02043, US
Name:
CONLEY, GregAddress:
Arlington, MA 02474-3803, US
Name:
NIXON, AndrewAddress:
Hanover, MA 02339, US
Name:
TENHOOR, ChristopherAddress:
Hopkinton, MA 01748, US
Name:
ADELMAN, BurtAddress:
Concord, MA 01742, US
Name:
CHYUNG, YungAddress:
Lexington, MA 02421, US
Priority
Number:
201361754607 PDate:
20.1.2013Country:
US
Classification
Categories:
C07K 16/40, G01N 33/50